FDA’s Pharmaceutical Regulatory Workload Picks Up In 2013 After Slow 2012
Congress likely to release $85 million in drug user fees that were taken out of the agency’s fiscal 2013 appropriations by sequestration, but it won’t boost FDA’s overall budget.
You may also be interested in...
Safeguarding America’s Pharmaceuticals Act passes on suspension calendar, but likely sets up fight with Senate in conference.
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.
EMD Serono has been tracking Serostim packages since 2002; J&J is using Prezista 600 mg as a trial run for serialization.